Business Overview

Operating Status
Dec 2019
B2B, B2C
Business Model
Offering Type
Vocalis Health is an AI healthtech company pioneering the development of vocal biomarkers where health-related information is derived from analysis of people's voice recordings to screen, detect, monitor and predict health symptoms, conditions and diseases. Vocalis Health is currently focused on screening users for COVID-19 and on monitoring patients with chronic diseases such as Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF) and Pulmonary Hypertension (PH).VocalisCheck is a software-only product that can be accessed via smartphones or other devices. Users simply count from 50 to 70, their voice recording is transformed to a picture (spectrogram) containing 512 features. That picture is then compared using AI machine learning/deep learning techniques to a composite picture based upon the voice recordings of COVID-19 positive participants in clinical trials to determine whether there is a high or low correlation between them. This technology can be integrated into existing mobile or web applications (via an SDK or Software Developers Kit) or can be accessed through a dedicated web-based portal.VocalisCheck is not intended to serve as a diagnostic tool. It is designed for use as a screening tool that can deliver a reliable risk score to guide who may need additional diagnostic testing, thereby enabling health systems to allocate diagnostic resources more efficiently.
Business Stage

Board Members and Advisors

Board Member
Board Member
Chairman and Board Member
Managing Partner and Board Member



Investor Type

Series Preference

Seed, Series A, Series B, Series C

Funding Rounds

Total Funding


Funding Rounds
Last Funding Series

Date Announced

Funding Round

Amount Raised


AI Technology Stack™

AI Team Size
AI Technologies
AI Description
AI Technologies
Coding Languages

Certifications and Approvals

February 2021

Research Publications

April 2020
Emerging data suggest that noninvasive voice biomarker analysis is associated with coronary artery disease. We recently showed that a vocal biomarker was associated with hospitalization and heart failure in patients with heart failure. We evaluate the association between a vocal biomarker and inv...
April 2020
Background The purpose of this article is to evaluate the association of voice signal analysis with adverse outcome among patients with congestive heart failure (CHF). Methods and Results The study cohort included 10 583 patients who were registered to a call center of patients who had chron...

In The News

Israeli startup Vocalis Health collabs with Mayo Clinic on AI-driven vocal biomarkers solution

Israeli startup Vocalis Health collabs with Mayo Clinic on AI-driven vocal biomarkers solution | Geektime

November 1, 2020

© 2021 All rights reserved.

You cannot copy content of this page

Sign up for free

  • Save profiles to your list
  • Basic search functionality

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database